Compare MRAM & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRAM | PROF |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.9M | 230.4M |
| IPO Year | 2016 | N/A |
| Metric | MRAM | PROF |
|---|---|---|
| Price | $12.02 | $8.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.50 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 276.6K | 198.1K |
| Earning Date | 02-25-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $53,642,000.00 | $14,297,000.00 |
| Revenue This Year | $11.00 | $64.23 |
| Revenue Next Year | $9.39 | $113.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.94 |
| 52 Week Low | $4.34 | $3.76 |
| 52 Week High | $13.00 | $8.62 |
| Indicator | MRAM | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 74.60 | 69.89 |
| Support Level | $9.03 | $7.33 |
| Resistance Level | $13.00 | $8.62 |
| Average True Range (ATR) | 0.66 | 0.46 |
| MACD | 0.31 | 0.05 |
| Stochastic Oscillator | 75.89 | 87.69 |
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.